WE WANT TO HEAR YOUR STORIES

Thank you for taking the time to share your story with us. By standing up and speaking out, we will smash the stigma and provide others with reassurance and support. Together we can stop the judgement of other women taking the morning after pill – one story at a time.

Name*

Last Name*

Remain anonymous*

Yes No

Did you use ellaOne?

Yes No

Where did you find us?*

Date of birth*

Email*

Location*

Tell us the story of your morning after*

Understand how your data is used:

Although your story can be kept anonymous if you wish, we have a responsibility to gather your data in line with our drug safety surveillance policy. Your data will never be shared without your permission. By submitting your story, you confirm that your information and personal data will be protected and kept confidential in line with our privacy policy and local regulations. The information you share may be used for the purpose of drug safety surveillance, to enable us to deal with your enquiry appropriately it may be shared with the relevant health authorities. You have a right of access to your personal data which we hold about you.
PLEASE NOTE, My Morning After story submissions may be quoted (anonymously) in newspaper and magazine articles, in the My Morning After podcast and on ellaOne social channels. By submitting your story you agree to these terms.
If you have selected PRETTY52 from the drop-down menu, your story may be anonymised further and used to inform marketing materials on PRETTY52 channels. Pretty 52 are visualising and recreating your submitted stories with the intention to broadcast and distribute on their social channels through the medium of video. Your identity will be kept strictly anonymous. Please note that submission of your story will be taken as permission and agreement to these terms and no fee or confirmation of use will be applied.

Do you have a question?

UKLOCustomerService@perrigo.com

Ask for the ellaOne Golden Shield tablet The UK's preferred morning after pill.*

ellaOne® 30mg film-coated tablet contains ulipristal acetate and is indicated for emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure.

*Based on sales data. Verify at ellaone.co.uk/verify

Always read the instructions on the package leaflet carefully. Health information within this website is provided for educational purposes only and is not intended to replace discussions with healthcare professionals. All decisions regarding patient care must be made with a healthcare professional considering the unique characteristics of the patient.

WE WANT TO HEAR YOUR STORIES

Thanks! Your story submission has been successful.

Your story submission is not successful. Please try again.